Immunoreactivity to Cetuximab in Cancer Patients

NCT00896896 · clinicaltrials.gov ↗
COMPLETED
Status
538
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Vanderbilt-Ingram Cancer Center

Collaborators